Childhood Craniopharyngioma Treatment - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Childhood Craniopharyngioma Treatment (PDQ®)

Patient Version Health Professional Version

Last Modified: 01/02/2009


Purpose of This PDQ Summary


General Information


Background Information About Childhood Craniopharyngioma


Histopathologic Classification of Childhood Craniopharyngioma


Diagnostic Evaluation of Childhood Craniopharyngioma


Stage Information


Treatment Options for Newly Diagnosed Childhood Craniopharyngioma


Treatment Options for Recurrent Childhood Craniopharyngioma


Late Effects in Patients Treated for Childhood Craniopharyngioma


Changes to the Summary (01/02/2009)


More Information

Page Options

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

Quit Smoking Today

	NCI Highlights


	Report to Nation Finds Declines in Cancer Incidence, Death Rates High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E The Nation's Investment in Cancer Research FY 2009 Past Highlights

Stage Information

There is no generally applied staging system for childhood craniopharyngiomas. Patients are classified as having newly diagnosed or recurrent disease.

< Previous Section | Next Section >

| | | | | | | |

A Service of the National Cancer Institute